Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous cultured chondrocytes versus autologous adipose-derived mesenchymal stem cells for knee chondral defect repair
2009-016628-29Phase 2Active
- Sponsor
- FIBHULP
- Start
- Jan 2012
- Modality
- Cell Therapies, Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous adipose-derived mesenchymal stromal cells and autologous cultured chondrocytes in cartilage defect of knee and knee osteoarthritis (OA) (2 arms), sponsored by FIBHULP. Primary endpoints: Clinical and functional outcomes, SF-12 score and 2 more. Started Jan 2012; status: active.
02
Drugs
autologous adipose-derived mesenchymal stromal cellsautologous cultured chondrocytes
03
Conditions
cartilage defect of kneeknee osteoarthritis (OA)
Beyond the preview
Go deeper on 2009-016628-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016628-29.